Search Results - "Thoreson, Gregory R."

Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging by Almeida S, Ricardo, Thomas, Jamie, Mason, Matthew M., Becerra, Maria F., Merhe, Ali, Reis, Isildinha M., Kwon, Deukwoo, Soodana‐Prakash, Nachiketh, Tewari, Ashutosh, Patel, Vipul, Wagaskar, Vinayak, Konety, Badrinath, Kasraeian, Ali, Czarniecki, Stefan, Thoreson, Gregory R., Kim, Eric H., Swain, Sanjaya, Parekh, Dipen J., Punnen, Sanoj

“…Objective The study aims to identify the optimal 4Kscore thresholds to determine the need for a prostate biopsy when multiparametric magnetic resonance imaging…”
Get full text

The Role of Systemic Chemotherapy in Management of Upper Tract Urothelial Cancer by Gayed, Bishoy A., Thoreson, Gregory R., Margulis, Vitaly

“…Upper tract urothelial cancer (UTUC) accounts for roughly 5 % of all urothelial cancers. At presentation, 30 % of patients demonstrate invasive and/or locally…”
Get full text

Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial by Vigneswaran, Hari T, Eklund, Martin, Discacciati, Andrea, Nordström, Tobias, Hubbard, Rebecca A, Perlis, Nathan, Abern, Michael R, Moreira, Daniel M, Eggener, Scott, Yonover, Paul, Chow, Alexander K, Watts, Kara, Liss, Michael A, Thoreson, Gregory R, Abreu, Andre L, Sonn, Geoffrey A, Palsdottir, Thorgerdur, Plym, Anna, Wiklund, Fredrik, Grönberg, Henrik, Murphy, Adam B

“…Asian, Black, and Hispanic men are underrepresented in prostate cancer (PCa) clinical trials. Few novel prostate cancer biomarkers have been validated in…”
Get full text

Does Pressure Regulating Balloon Location Make a Difference in Functional Outcomes of Artificial Urinary Sphincter? by Singla, Nirmish, Siegel, Jordan A, Simhan, Jay, Tausch, Timothy J, Klein, Alexandra, Thoreson, Gregory R, Morey, Allen F

“…Purpose We compared functional outcomes in patients who received an artificial urinary sphincter in the space of Retzius vs the same device placed at a high…”
Get full text

Predicting Renal Parenchymal Loss after Nephron Sparing Surgery by Meyer, Alexa, Woldu, Solomon L, Weinberg, Aaron C, Thoreson, Gregory R, Pierorazio, Phillip, Matulay, Justin T, Benson, Mitchell C, DeCastro, G. Joel, McKiernan, James M

“…Purpose We analyze the relationship among various patient, operative and tumor characteristics to determine which factors correlate with renal parenchymal…”
Get full text

Comparison of Renal Parenchymal Volume Preservation Between Partial Nephrectomy, Cryoablation, and Radiofrequency Ablation Using 3D Volume Measurements by Woldu, Solomon L, Thoreson, Gregory R, Okhunov, Zhamshid, Ghandour, Rashed, Rothberg, Michael B, RoyChoudhury, Arindam, Kim, Helen H R, Bozoghlanian, Mari, Newhouse, Jeffrey H, Helmy, Mohammad A, Badani, Ketan K, Landman, Jamie, Cadeddu, Jeffrey A, McKiernan, James M

“…Small renal masses (SRM) can be managed via a variety of nephron-sparing procedures (NSPs), but the association between choice of NSP and renal parenchymal…”
Get more information

Emerging therapies in castration resistant prostate cancer by Thoreson, Gregory R, Gayed, Bishoy A, Chung, Paul H, Raj, Ganesh V

“…Prostate cancer continues to be the second leading cause of cancer related mortality in men within the United States. Despite a consistent decline in prostate…”
Get more information

Emerging drugs for prostate cancer by Chung, Paul H, Gayed, Bishoy A, Thoreson, Gregory R, Raj, Ganesh V

“…Androgen deprivation therapy is the mainstay treatment for patients with prostate cancer who are not candidates for definitive treatment, are diagnosed with…”
Get more information

The Evolution of Systemic Therapy in Metastatic Renal Cell Carcinoma by Hutson, Thomas E, Thoreson, Gregory R, Figlin, Robert A, Rini, Brian I

“…The treatment landscape for renal cell carcinoma (RCC) is a dynamic process that has seen considerable change in recent years. We have seen a rebirth of…”
Get more information

Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial by Vigneswaran, Hari Thambiah, Eklund, Martin, Discacciati, Andrea, Nordström, Tobias, Hubbard, Rebecca A., Perlis, Nathan, Abern, Michael, Moreira, Daniel, Eggener, Scott E., Yonover, Paul M., Chow, Alexander, Watts, Kara, Liss, Michael A., Thoreson, Gregory R, Abreu, Andre Luis, Sonn, Geoffrey A, Palsdottir, Thorgerdur, Wiklund, Fredrik, Gronberg, Henrik, Murphy, Adam B

“…262 Background: Stockholm3 is a multiparametric blood test incorporating germline risk, proteins and clinical data which improves prostate cancer (PC) risk…”
Get full text